Cargando…

Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights

Very-low-density lipoprotein (VLDL) is the only lipoprotein containing apolipoprotein B that is secreted from the liver, where VLDL is assembled from apolipoproteins, cholesterol, and triglycerides. The primary function of VLDL is to transport cholesterol and other lipids to organs and cells for uti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hsiang-Chun, Akhmedov, Alexander, Chen, Chu-Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577298/ https://www.ncbi.nlm.nih.gov/pubmed/36267630 http://dx.doi.org/10.3389/fcvm.2022.993633

Ejemplares similares

Editorial: Implications of lipids and modified lipoproteins in atherogenesis: from mechanisms towards novel diagnostic and therapeutic targets
por: Kraler, Simon, et al.
Publicado: (2023)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

Sex-Differences in Aortic Stenosis: Mechanistic Insights and Clinical Implications
por: Matilla, Lara, et al.
Publicado: (2022)

Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
por: Huang, Jih-Kai, et al.
Publicado: (2022)

Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study
por: De Luca, Leonardo, et al.
Publicado: (2022)

The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2020)

Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice
por: Lin, Ying-Shao, et al.
Publicado: (2021)

Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation
por: Dietrich, Elisa, et al.
Publicado: (2022)

Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor
por: Hsu, Jing-Fang, et al.
Publicado: (2014)

Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit
por: Brites, Fernando, et al.
Publicado: (2017)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction
por: Lee, Hsiang-Chun, et al.
Publicado: (2017)

Why Should We Measure Low-Density Lipoprotein Cholesterol Directly? Comparison of Low-Density Lipoprotein Cholesterol Assessment by Friedewald Estimation, and Direct Measurement
por: Cohen, Hofit
Publicado: (2021)

High-Density Lipoprotein – A Hero, a Mirage, or a Witness?
por: Sviridov, Dmitri
Publicado: (2014)

Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis
por: Mao, Hua, et al.
Publicado: (2017)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2020)

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein
Publicado: (1982)

Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron
por: Vinchi, Francesca
Publicado: (2021)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Identification and Characterization of the Very-Low-Density Lipoprotein Receptor Gene from Branchiostoma belcheri: Insights into the Origin and Evolution of the Low-Density Lipoprotein Receptor Gene Family
por: Cao, Yunpeng, et al.
Publicado: (2023)

Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential
por: Sweet, David R., et al.
Publicado: (2018)

Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
por: Jain, Ashita, et al.
Publicado: (2023)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
por: Potere, Nicola, et al.
Publicado: (2019)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2023)

Serotonin—A Driver of Progressive Heart Valve Disease
por: Waldum, Helge, et al.
Publicado: (2022)

Comparison of aerobic and combined aerobic and resistance training on low-density lipoprotein cholesterol concentrations in men
por: Shaw, Ina, et al.
Publicado: (2009)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights
por: Gander, Joséphine, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Graves’ disease as a driver of depression: a mechanistic insight
por: Song, Yifei, et al.
Publicado: (2023)

Prevalence of cardiometabolic risk factors among professional male long–distance bus drivers in Lagos, south–west Nigeria: a cross–sectional study
por: Casmir, E Amadi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_03vatct5onv1ov5k6i0cppk0cb